News, views and contacts from the global Drugdevelopment industry

Today on Drug Development Technology

ONZETRA Xsail for the Treatment of Migraine in Adults

ONZETRA Xsail is a Food and Drug Administration (FDA)-approved intranasal dry powder formulation developed by Avanir Pharmaceuticals.

Defitelio (defibrotide sodium) for the Treatment of Hepatic Veno-Occlusive Disease

Defitelio (defibrotide sodium) is an injectable drug developed by Jazz Pharmaceuticals, for the treatment of hepatic veno-occlusive...

Cinqair (reslizumab) Injection for treatment of Severe Asthma and an Eosinophilic Phenotype

Cinqair is an injectable formulation of reslizumab developed by Teva Pharmaceuticals for the treatment of severe asthma and eosinophilic...

Descovy (emtricitabine, tenofovir alafenamide) for the Treatment of HIV-1 Infection

Descovy (emtricitabine200mg/tenofovir alafenamide25mg, F/TAF) is developed by Gilead sciences for the treatment of HIV-1 infection in...


Latest Suppliers

Kemwell
Kemwell has been providing CDMO services to pharmaceutical and biopharmaceutical clients globally for more than three decades. Kemwell scientists are specialists in dosage form...
See all suppliers

cachename:HomePagecachekey:rd-1665407042_1729060782_rd-488908060_1460672566_ap1460672566_1729060782_1903286115